Khurram Jamil
Chief Medical Officer · GALECTIN THERAPEUTICS INC
- 2024
- Jul 16, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Khurram Jamil files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 10X Fund, L.P. - $2.19M in GALT purchases and sales in the last 12 months
- Jack W. Callicutt - $944K in GALT purchases and sales in the last 12 months
- Joel Lewis - $621K in GALT purchases and sales in the last 12 months
- Harold H. Shlevin - $501K in GALT purchases and sales in the last 12 months
- Kevin D. Freeman - $20K in GALT purchases and sales in the last 12 months
- Kary Eldred - $3K in GALT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Khurram Jamil?
Khurram Jamil is a corporate insider, tracked as Chief Medical Officer of GALECTIN THERAPEUTICS INC (GALT). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Khurram Jamil last file a Form 4?
The most recent primary Form 4 on record is dated 16 July 2026, one of 10 filings going back to 2024.
Has Khurram Jamil been buying or selling stock?
Recorded transactions: 0 open-market purchases and 18 open-market sales ($1.45M) across all tracked filings.
